HOSTDX Trademark

Trademark Overview


On Wednesday, April 27, 2022, a trademark application was filed for HOSTDX with the United States Patent and Trademark Office. The USPTO has given the HOSTDX trademark a serial number of 97384900. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, September 23, 2024. This trademark is owned by Inflammatix, Inc.. The HOSTDX trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical diagnostic reagents and assays for use in gene expression tests, gene expression profiling assays, analyzing genetic information, analyzing and detecting protein biomarkers, analysis of biomarker levels and/or for use in analyzing relative expressions of host response

Medical diagnostic services in the field of diagnostic testing services; medical diagnostic services for gene expression testing, gene expression profiling, analyzing genetic information, analyzing and detecting protein biomarkers, analyzing biomarker levels, analyzing relative expressions of host response, analyzing clinical data, and/or analyzing demographic information

Medical and diagnostic apparatus for use in gene expression tests, gene expression profiling assays, analyzing genetic information, analyzing and detecting protein biomarkers, analyzing clinical data, and/or analyzing demographic information; medical and diagnostic apparatus for analysis of biomarker levels and/or relative expression of host response genes; medical and diagnostic apparatus for analyzing gene expression tests using bioinformatics and machine learning algorithms; medical and diagnostic apparatus for gene expression tests, gene expression profiling assays, analyzing genetic information, analyzing protein biomarkers, analyzing clinical data, and/or analyzing demographic information to aid treatment decisions

Medical research, namely, development of rapid medical tests and molecular diagnostic tests using bioinformatics, algorithms, and machine learning; development of medical tests based on the immune system and immune responses, gene expression, protein biomarker levels, genetic information, demographic information and/or clinical data, for medical purposes
hostdx

General Information


Serial Number97384900
Word MarkHOSTDX
Filing DateWednesday, April 27, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, September 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 30, 2024

Trademark Statements


Goods and ServicesMedical diagnostic reagents and assays for use in gene expression tests, gene expression profiling assays, analyzing genetic information, analyzing and detecting protein biomarkers, analysis of biomarker levels and/or for use in analyzing relative expressions of host response
Goods and ServicesMedical diagnostic services in the field of diagnostic testing services; medical diagnostic services for gene expression testing, gene expression profiling, analyzing genetic information, analyzing and detecting protein biomarkers, analyzing biomarker levels, analyzing relative expressions of host response, analyzing clinical data, and/or analyzing demographic information
Goods and ServicesMedical and diagnostic apparatus for use in gene expression tests, gene expression profiling assays, analyzing genetic information, analyzing and detecting protein biomarkers, analyzing clinical data, and/or analyzing demographic information; medical and diagnostic apparatus for analysis of biomarker levels and/or relative expression of host response genes; medical and diagnostic apparatus for analyzing gene expression tests using bioinformatics and machine learning algorithms; medical and diagnostic apparatus for gene expression tests, gene expression profiling assays, analyzing genetic information, analyzing protein biomarkers, analyzing clinical data, and/or analyzing demographic information to aid treatment decisions
Goods and ServicesMedical research, namely, development of rapid medical tests and molecular diagnostic tests using bioinformatics, algorithms, and machine learning; development of medical tests based on the immune system and immune responses, gene expression, protein biomarker levels, genetic information, demographic information and/or clinical data, for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, May 3, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 3, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 3, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInflammatix, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSunnyvale, CA 94085

Party NameInflammatix, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSunnyvale, CA 94085

Trademark Events


Event DateEvent Description
Saturday, April 30, 2022NEW APPLICATION ENTERED
Tuesday, May 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 2, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 2, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 30, 2022ASSIGNED TO EXAMINER
Friday, December 30, 2022NON-FINAL ACTION WRITTEN
Friday, December 30, 2022NON-FINAL ACTION E-MAILED
Friday, December 30, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 1, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, February 1, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, June 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 28, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 28, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 30, 2023ASSIGNED TO LIE
Thursday, November 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 30, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 23, 2024SOU TEAS EXTENSION RECEIVED
Monday, September 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 23, 2024SOU EXTENSION 1 GRANTED
Monday, September 23, 2024SOU EXTENSION 1 FILED